ReP USP - Resultado da busca

Artigo de periodico
Targeted liposomes: a nonviral gene delivery system for cancer therapy (2022)
Luiz, Marcela Tavares ; Dutra, Jessyca Aparecida Paes; Tofani, Larissa Bueno; Araújo, Jennifer Thayanne Cavalcante de; Filippo, Leonardo Delello Di; Marchetti, Juliana Maldonado ; Chorilli, Marlus
Source: Pharmaceutics. Unidade: FCFRP
Subjects: LIPOSSOMOS, GENES, NEOPLASIAS, RNA, GENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LUIZ, Marcela Tavares et al. Targeted liposomes: a nonviral gene delivery system for cancer therapy. Pharmaceutics, v. 14, n. 4, p. 1-31, 2022Tradução . . Disponível em: https://doi.org/10.3390/pharmaceutics14040821. Acesso em: 14 jun. 2024.
APA
Luiz, M. T., Dutra, J. A. P., Tofani, L. B., Araújo, J. T. C. de, Filippo, L. D. D., Marchetti, J. M., & Chorilli, M. (2022). Targeted liposomes: a nonviral gene delivery system for cancer therapy. Pharmaceutics, 14( 4), 1-31. doi:10.3390/pharmaceutics14040821
NLM
Luiz MT, Dutra JAP, Tofani LB, Araújo JTC de, Filippo LDD, Marchetti JM, Chorilli M. Targeted liposomes: a nonviral gene delivery system for cancer therapy [Internet]. Pharmaceutics. 2022 ; 14( 4): 1-31.[citado 2024 jun. 14 ] Available from: https://doi.org/10.3390/pharmaceutics14040821
Vancouver
Luiz MT, Dutra JAP, Tofani LB, Araújo JTC de, Filippo LDD, Marchetti JM, Chorilli M. Targeted liposomes: a nonviral gene delivery system for cancer therapy [Internet]. Pharmaceutics. 2022 ; 14( 4): 1-31.[citado 2024 jun. 14 ] Available from: https://doi.org/10.3390/pharmaceutics14040821
Artigo de periodico
Design of experiments (DoE) to develop and to optimize nanoparticles as drug delivery systems (2021)
Luiz, Marcela Tavares; Viegas, Juliana Santos Rosa ; Abriata, Juliana Palma; Viegas, Felipe; Vicentini, Fabiana Testa Moura-de-Carvalho ; Bentley, Maria Vitória Lopes Badra ; Chorilli, Marlus; Marchetti, Juliana Maldonado; Tapia-Blacido, Delia Rita
Source: European Journal of Pharmaceutics and Biopharmaceutics. Unidades: FCFRP, FFCLRP
Subjects: NANOTECNOLOGIA, NANOPARTÍCULAS, DESIGNS (CONFIGURAÇÕES COMBINATÓRIAS), SISTEMAS DE DISTRIBUIÇÃO DE MEDICAMENTOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LUIZ, Marcela Tavares et al. Design of experiments (DoE) to develop and to optimize nanoparticles as drug delivery systems. European Journal of Pharmaceutics and Biopharmaceutics, v. 165, p. 127-148, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.ejpb.2021.05.011. Acesso em: 14 jun. 2024.
APA
Luiz, M. T., Viegas, J. S. R., Abriata, J. P., Viegas, F., Vicentini, F. T. M. -de-C., Bentley, M. V. L. B., et al. (2021). Design of experiments (DoE) to develop and to optimize nanoparticles as drug delivery systems. European Journal of Pharmaceutics and Biopharmaceutics, 165, 127-148. doi:10.1016/j.ejpb.2021.05.011
NLM
Luiz MT, Viegas JSR, Abriata JP, Viegas F, Vicentini FTM-de-C, Bentley MVLB, Chorilli M, Marchetti JM, Tapia-Blacido DR. Design of experiments (DoE) to develop and to optimize nanoparticles as drug delivery systems [Internet]. European Journal of Pharmaceutics and Biopharmaceutics. 2021 ; 165 127-148.[citado 2024 jun. 14 ] Available from: https://doi.org/10.1016/j.ejpb.2021.05.011
Vancouver
Luiz MT, Viegas JSR, Abriata JP, Viegas F, Vicentini FTM-de-C, Bentley MVLB, Chorilli M, Marchetti JM, Tapia-Blacido DR. Design of experiments (DoE) to develop and to optimize nanoparticles as drug delivery systems [Internet]. European Journal of Pharmaceutics and Biopharmaceutics. 2021 ; 165 127-148.[citado 2024 jun. 14 ] Available from: https://doi.org/10.1016/j.ejpb.2021.05.011
Artigo de periodico
Anti-EGFR liquid crystalline nanodispersions for docetaxel delivery: formulation, characterization and cytotoxicity in cancer cells (2021)
Trevizan, Lucas Noboru Fatori; Eloy, Josimar O; Luiz, Marcela Tavares ; Petrilli, Raquel ; Ramos Junior, Sergio Luiz; Borges, Julio Cesar ; Marchetti, Juliana Maldonado ; Chorilli, Marlus
Source: Colloids and Surfaces A: Physicochemical and Engineering Aspects. Unidades: IQSC, FCFRP
Subjects: NEOPLASIAS, PRÓSTATA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TREVIZAN, Lucas Noboru Fatori et al. Anti-EGFR liquid crystalline nanodispersions for docetaxel delivery: formulation, characterization and cytotoxicity in cancer cells. Colloids and Surfaces A: Physicochemical and Engineering Aspects, v. 613, p. 126058, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.colsurfa.2020.126058. Acesso em: 14 jun. 2024.
APA
Trevizan, L. N. F., Eloy, J. O., Luiz, M. T., Petrilli, R., Ramos Junior, S. L., Borges, J. C., et al. (2021). Anti-EGFR liquid crystalline nanodispersions for docetaxel delivery: formulation, characterization and cytotoxicity in cancer cells. Colloids and Surfaces A: Physicochemical and Engineering Aspects, 613, 126058. doi:10.1016/j.colsurfa.2020.126058
NLM
Trevizan LNF, Eloy JO, Luiz MT, Petrilli R, Ramos Junior SL, Borges JC, Marchetti JM, Chorilli M. Anti-EGFR liquid crystalline nanodispersions for docetaxel delivery: formulation, characterization and cytotoxicity in cancer cells [Internet]. Colloids and Surfaces A: Physicochemical and Engineering Aspects. 2021 ; 613 126058.[citado 2024 jun. 14 ] Available from: https://doi.org/10.1016/j.colsurfa.2020.126058
Vancouver
Trevizan LNF, Eloy JO, Luiz MT, Petrilli R, Ramos Junior SL, Borges JC, Marchetti JM, Chorilli M. Anti-EGFR liquid crystalline nanodispersions for docetaxel delivery: formulation, characterization and cytotoxicity in cancer cells [Internet]. Colloids and Surfaces A: Physicochemical and Engineering Aspects. 2021 ; 613 126058.[citado 2024 jun. 14 ] Available from: https://doi.org/10.1016/j.colsurfa.2020.126058
Artigo de periodico
Generation of a three-dimensional in vitro ovarian cancer co-culture model for drug screening assays (2021)
Tofani, Larissa Bueno; Sousa, Lucas Oliveira ; Luiz, Marcela Tavares; Abriata, Juliana Palma; Marchetti, Juliana Maldonado; Leopoldino, Andréia Machado ; Swiech, Kamilla
Source: Journal of Pharmaceutical Sciences. Unidade: FCFRP
Subjects: LINHAGEM CELULAR, AVALIAÇÃO DE MEDICAMENTOS, NEOPLASIAS OVARIANAS, FARMACOTERAPIA, FIBROBLASTOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TOFANI, Larissa Bueno et al. Generation of a three-dimensional in vitro ovarian cancer co-culture model for drug screening assays. Journal of Pharmaceutical Sciences, v. 110, n. 7, p. 2629-2636, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.xphs.2021.04.003. Acesso em: 14 jun. 2024.
APA
Tofani, L. B., Sousa, L. O., Luiz, M. T., Abriata, J. P., Marchetti, J. M., Leopoldino, A. M., & Swiech, K. (2021). Generation of a three-dimensional in vitro ovarian cancer co-culture model for drug screening assays. Journal of Pharmaceutical Sciences, 110( 7), 2629-2636. doi:10.1016/j.xphs.2021.04.003
NLM
Tofani LB, Sousa LO, Luiz MT, Abriata JP, Marchetti JM, Leopoldino AM, Swiech K. Generation of a three-dimensional in vitro ovarian cancer co-culture model for drug screening assays [Internet]. Journal of Pharmaceutical Sciences. 2021 ; 110( 7): 2629-2636.[citado 2024 jun. 14 ] Available from: https://doi.org/10.1016/j.xphs.2021.04.003
Vancouver
Tofani LB, Sousa LO, Luiz MT, Abriata JP, Marchetti JM, Leopoldino AM, Swiech K. Generation of a three-dimensional in vitro ovarian cancer co-culture model for drug screening assays [Internet]. Journal of Pharmaceutical Sciences. 2021 ; 110( 7): 2629-2636.[citado 2024 jun. 14 ] Available from: https://doi.org/10.1016/j.xphs.2021.04.003
Artigo de periodico
Transferrin-functionalized liposomes for docetaxel delivery to prostate cancer cells (2021)
Fernandes, Mariza Aires; Eloy, Josimar O; Luiz, Marcela Tavares ; Ramos Junior, Sergio Luiz; Borges, Julio Cesar ; la Fuente, Laura Rodríguez de; San Luis, Clara Ortega-de; Marchetti, Juliana Maldonado ; Martinez, Maria J. Santos; Chorilli, Marlus
Source: Colloids and Surfaces A: Physicochemical and Engineering Aspects. Unidades: IQSC, FCFRP
Subjects: NEOPLASIAS, PRÓSTATA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERNANDES, Mariza Aires et al. Transferrin-functionalized liposomes for docetaxel delivery to prostate cancer cells. Colloids and Surfaces A: Physicochemical and Engineering Aspects, n. 125806, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.colsurfa.2020.125806. Acesso em: 14 jun. 2024.
APA
Fernandes, M. A., Eloy, J. O., Luiz, M. T., Ramos Junior, S. L., Borges, J. C., la Fuente, L. R. de, et al. (2021). Transferrin-functionalized liposomes for docetaxel delivery to prostate cancer cells. Colloids and Surfaces A: Physicochemical and Engineering Aspects, ( 125806). doi:10.1016/j.colsurfa.2020.125806
NLM
Fernandes MA, Eloy JO, Luiz MT, Ramos Junior SL, Borges JC, la Fuente LR de, San Luis CO-de, Marchetti JM, Martinez MJS, Chorilli M. Transferrin-functionalized liposomes for docetaxel delivery to prostate cancer cells [Internet]. Colloids and Surfaces A: Physicochemical and Engineering Aspects. 2021 ;( 125806):[citado 2024 jun. 14 ] Available from: https://doi.org/10.1016/j.colsurfa.2020.125806
Vancouver
Fernandes MA, Eloy JO, Luiz MT, Ramos Junior SL, Borges JC, la Fuente LR de, San Luis CO-de, Marchetti JM, Martinez MJS, Chorilli M. Transferrin-functionalized liposomes for docetaxel delivery to prostate cancer cells [Internet]. Colloids and Surfaces A: Physicochemical and Engineering Aspects. 2021 ;( 125806):[citado 2024 jun. 14 ] Available from: https://doi.org/10.1016/j.colsurfa.2020.125806
Artigo de periodico
Establishment and characterization of an in vitro 3D ovarian cancer model for drug screening assays (2020)
Tofani, Larissa Bueno ; Abriata, Juliana Palma ; Luiz, Marcela Tavares ; Marchetti, Juliana Maldonado ; Swiech, Kamilla
Source: Biotechnology Progress. Unidade: FCFRP
Subjects: NEOPLASIAS OVARIANAS, FÁRMACOS, BIOTECNOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TOFANI, Larissa Bueno et al. Establishment and characterization of an in vitro 3D ovarian cancer model for drug screening assays. Biotechnology Progress, v. 36, n. 6, p. 1-11, 2020Tradução . . Disponível em: https://doi.org/10.1002/btpr.3034. Acesso em: 14 jun. 2024.
APA
Tofani, L. B., Abriata, J. P., Luiz, M. T., Marchetti, J. M., & Swiech, K. (2020). Establishment and characterization of an in vitro 3D ovarian cancer model for drug screening assays. Biotechnology Progress, 36( 6), 1-11. doi:10.1002/btpr.3034
NLM
Tofani LB, Abriata JP, Luiz MT, Marchetti JM, Swiech K. Establishment and characterization of an in vitro 3D ovarian cancer model for drug screening assays [Internet]. Biotechnology Progress. 2020 ; 36( 6): 1-11.[citado 2024 jun. 14 ] Available from: https://doi.org/10.1002/btpr.3034
Vancouver
Tofani LB, Abriata JP, Luiz MT, Marchetti JM, Swiech K. Establishment and characterization of an in vitro 3D ovarian cancer model for drug screening assays [Internet]. Biotechnology Progress. 2020 ; 36( 6): 1-11.[citado 2024 jun. 14 ] Available from: https://doi.org/10.1002/btpr.3034
Artigo de periodico
EGFR-targeted immunoliposomes efficiently deliver docetaxel to prostate cancer cells (2020)
Eloya, Josimar O.; Ruiz, Amalia ; Lima, Felipe Tita de ; Petrilli, Raquel ; Raspantini, Giovanni Loureiro ; Nogueira, Karina Alexandre Barros ; Santos, Elias; Oliveira, Carlos Sabino de ; Borges, Julio Cesar ; Marchetti, Juliana Maldonado ; Al-Jamal, Wafa T.; Chorilli, Marlus
Source: Colloids and Surfaces B: Biointerfaces. Unidades: IQSC, FCFRP, FCF
Subjects: BIOQUÍMICA, NEOPLASIAS, PRÓSTATA, MEDICAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ELOYA, Josimar O. et al. EGFR-targeted immunoliposomes efficiently deliver docetaxel to prostate cancer cells. Colloids and Surfaces B: Biointerfaces, v. 194, p. 111185, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.colsurfb.2020.111185. Acesso em: 14 jun. 2024.
APA
Eloya, J. O., Ruiz, A., Lima, F. T. de, Petrilli, R., Raspantini, G. L., Nogueira, K. A. B., et al. (2020). EGFR-targeted immunoliposomes efficiently deliver docetaxel to prostate cancer cells. Colloids and Surfaces B: Biointerfaces, 194, 111185. doi:10.1016/j.colsurfb.2020.111185
NLM
Eloya JO, Ruiz A, Lima FT de, Petrilli R, Raspantini GL, Nogueira KAB, Santos E, Oliveira CS de, Borges JC, Marchetti JM, Al-Jamal WT, Chorilli M. EGFR-targeted immunoliposomes efficiently deliver docetaxel to prostate cancer cells [Internet]. Colloids and Surfaces B: Biointerfaces. 2020 ; 194 111185.[citado 2024 jun. 14 ] Available from: https://doi.org/10.1016/j.colsurfb.2020.111185
Vancouver
Eloya JO, Ruiz A, Lima FT de, Petrilli R, Raspantini GL, Nogueira KAB, Santos E, Oliveira CS de, Borges JC, Marchetti JM, Al-Jamal WT, Chorilli M. EGFR-targeted immunoliposomes efficiently deliver docetaxel to prostate cancer cells [Internet]. Colloids and Surfaces B: Biointerfaces. 2020 ; 194 111185.[citado 2024 jun. 14 ] Available from: https://doi.org/10.1016/j.colsurfb.2020.111185
Artigo de periodico
In vitro evaluation of folate-modified PLGA nanoparticles containing paclitaxel for ovarian cancer therapy (2019)
Luiz, Marcela Tavares ; Abriata, Juliana Palma ; Raspantini, Giovanni Loureiro ; Tofani, Larissa Bueno ; Fumagalli, Fernando ; Melo, Shaiani Maria Gil de ; Emery, Flavio da Silva ; Swiech, Kamilla ; Marcato, Priscyla Daniely ; Lee, Robert; Marchetti, Juliana Maldonado
Source: Materials Science & Engineering C. Unidade: FCFRP
Subjects: QUIMIOTERAPIA, ÁCIDO FÓLICO, NEOPLASIAS OVARIANAS, NANOPARTÍCULAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LUIZ, Marcela Tavares et al. In vitro evaluation of folate-modified PLGA nanoparticles containing paclitaxel for ovarian cancer therapy. Materials Science & Engineering C, v. 105, p. e110038, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.msec.2019.110038. Acesso em: 14 jun. 2024.
APA
Luiz, M. T., Abriata, J. P., Raspantini, G. L., Tofani, L. B., Fumagalli, F., Melo, S. M. G. de, et al. (2019). In vitro evaluation of folate-modified PLGA nanoparticles containing paclitaxel for ovarian cancer therapy. Materials Science & Engineering C, 105, e110038. doi:10.1016/j.msec.2019.110038
NLM
Luiz MT, Abriata JP, Raspantini GL, Tofani LB, Fumagalli F, Melo SMG de, Emery F da S, Swiech K, Marcato PD, Lee R, Marchetti JM. In vitro evaluation of folate-modified PLGA nanoparticles containing paclitaxel for ovarian cancer therapy [Internet]. Materials Science & Engineering C. 2019 ; 105 e110038.[citado 2024 jun. 14 ] Available from: https://doi.org/10.1016/j.msec.2019.110038
Vancouver
Luiz MT, Abriata JP, Raspantini GL, Tofani LB, Fumagalli F, Melo SMG de, Emery F da S, Swiech K, Marcato PD, Lee R, Marchetti JM. In vitro evaluation of folate-modified PLGA nanoparticles containing paclitaxel for ovarian cancer therapy [Internet]. Materials Science & Engineering C. 2019 ; 105 e110038.[citado 2024 jun. 14 ] Available from: https://doi.org/10.1016/j.msec.2019.110038
Artigo de periodico
Development, characterization and biological in vitro assays of paclitaxel-loaded PCL polymeric nanoparticles (2019)
Abriata, Juliana Palma ; Turatti, Roger Casanova ; Luiz, Marcela Tavares ; Raspantini, Giovanni Loureiro ; Tofani, Larissa Bueno ; Amaral, Robson Luis Ferraz do ; Swiech, Kamilla ; Gaspari, Priscyla Daniely Marcato ; Marchetti, Juliana Maldonado
Source: Materials Science and Engineering: C. Unidade: FCFRP
Subjects: ADENOCARCINOMA, NANOTECNOLOGIA, NEOPLASIAS DOS GENITAIS FEMININOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ABRIATA, Juliana Palma et al. Development, characterization and biological in vitro assays of paclitaxel-loaded PCL polymeric nanoparticles. Materials Science and Engineering: C, v. 96, p. 347-355, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.msec.2018.11.035. Acesso em: 14 jun. 2024.
APA
Abriata, J. P., Turatti, R. C., Luiz, M. T., Raspantini, G. L., Tofani, L. B., Amaral, R. L. F. do, et al. (2019). Development, characterization and biological in vitro assays of paclitaxel-loaded PCL polymeric nanoparticles. Materials Science and Engineering: C, 96, 347-355. doi:10.1016/j.msec.2018.11.035
NLM
Abriata JP, Turatti RC, Luiz MT, Raspantini GL, Tofani LB, Amaral RLF do, Swiech K, Gaspari PDM, Marchetti JM. Development, characterization and biological in vitro assays of paclitaxel-loaded PCL polymeric nanoparticles [Internet]. Materials Science and Engineering: C. 2019 ; 96 347-355.[citado 2024 jun. 14 ] Available from: https://doi.org/10.1016/j.msec.2018.11.035
Vancouver
Abriata JP, Turatti RC, Luiz MT, Raspantini GL, Tofani LB, Amaral RLF do, Swiech K, Gaspari PDM, Marchetti JM. Development, characterization and biological in vitro assays of paclitaxel-loaded PCL polymeric nanoparticles [Internet]. Materials Science and Engineering: C. 2019 ; 96 347-355.[citado 2024 jun. 14 ] Available from: https://doi.org/10.1016/j.msec.2018.11.035
Artigo de periodico
Development and evaluation of a nanoemulsion containing ursolic acid: a promising Trypanocidal agent (2017)
Oliveira, Erika Cristina Vargas de; Carneiro, Zumira Aparecida; Albuquerque, Sérgio de; Marchetti, Juliana Maldonado
Source: AAPS PharmSciTech. Unidade: FCFRP
Subjects: DOENÇA DE CHAGAS, NANOPARTÍCULAS, TRIPANOSSOMICIDAS, EMULSÕES (FORMAS FARMACÊUTICAS)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, Erika Cristina Vargas de et al. Development and evaluation of a nanoemulsion containing ursolic acid: a promising Trypanocidal agent. AAPS PharmSciTech, v. 18, n. 7, p. 2551-2560, 2017Tradução . . Disponível em: https://doi.org/10.1208/s12249-017-0736-y. Acesso em: 14 jun. 2024.
APA
Oliveira, E. C. V. de, Carneiro, Z. A., Albuquerque, S. de, & Marchetti, J. M. (2017). Development and evaluation of a nanoemulsion containing ursolic acid: a promising Trypanocidal agent. AAPS PharmSciTech, 18( 7), 2551-2560. doi:10.1208/s12249-017-0736-y
NLM
Oliveira ECV de, Carneiro ZA, Albuquerque S de, Marchetti JM. Development and evaluation of a nanoemulsion containing ursolic acid: a promising Trypanocidal agent [Internet]. AAPS PharmSciTech. 2017 ; 18( 7): 2551-2560.[citado 2024 jun. 14 ] Available from: https://doi.org/10.1208/s12249-017-0736-y
Vancouver
Oliveira ECV de, Carneiro ZA, Albuquerque S de, Marchetti JM. Development and evaluation of a nanoemulsion containing ursolic acid: a promising Trypanocidal agent [Internet]. AAPS PharmSciTech. 2017 ; 18( 7): 2551-2560.[citado 2024 jun. 14 ] Available from: https://doi.org/10.1208/s12249-017-0736-y
Artigo de periodico
Poly-epsilon-caprolactone nanoparticles enhance ursolic acid in vivo efficacy against Trypanosoma cruzi infection (2017)
Abriata, Juliana Palma; Eloy, Josimar O.; Riul, Thalita Bachelli; Campos, Patricia Mazureki; Baruffi, Marcelo Dias; Marchetti, Juliana Maldonado
Source: Materials Science and Engineering: C. Unidade: FCFRP
Subjects: NANOPARTÍCULAS, TRYPANOSOMA CRUZI, DOENÇA DE CHAGAS, BIODISPONIBILIDADE, FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ABRIATA, Juliana Palma et al. Poly-epsilon-caprolactone nanoparticles enhance ursolic acid in vivo efficacy against Trypanosoma cruzi infection. Materials Science and Engineering: C, v. 77, p. 1196-1203, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.msec.2017.03.266. Acesso em: 14 jun. 2024.
APA
Abriata, J. P., Eloy, J. O., Riul, T. B., Campos, P. M., Baruffi, M. D., & Marchetti, J. M. (2017). Poly-epsilon-caprolactone nanoparticles enhance ursolic acid in vivo efficacy against Trypanosoma cruzi infection. Materials Science and Engineering: C, 77, 1196-1203. doi:10.1016/j.msec.2017.03.266
NLM
Abriata JP, Eloy JO, Riul TB, Campos PM, Baruffi MD, Marchetti JM. Poly-epsilon-caprolactone nanoparticles enhance ursolic acid in vivo efficacy against Trypanosoma cruzi infection [Internet]. Materials Science and Engineering: C. 2017 ; 77 1196-1203.[citado 2024 jun. 14 ] Available from: https://doi.org/10.1016/j.msec.2017.03.266
Vancouver
Abriata JP, Eloy JO, Riul TB, Campos PM, Baruffi MD, Marchetti JM. Poly-epsilon-caprolactone nanoparticles enhance ursolic acid in vivo efficacy against Trypanosoma cruzi infection [Internet]. Materials Science and Engineering: C. 2017 ; 77 1196-1203.[citado 2024 jun. 14 ] Available from: https://doi.org/10.1016/j.msec.2017.03.266
Artigo de periodico
Anti-HER2 immunoliposomes for co-delivery of paclitaxel and rapamycin for breast cancer therapy (2017)
Eloy, Josimar O.; Petrilli, Raquel; Chesca, Deise Lúcia; Saggioro, Fabiano Pinto; Lee, Robert J.; Marchetti, Juliana Maldonado
Source: European Journal of Pharmaceutics and Biopharmaceutics. Unidades: FMRP, SVOI, FCFRP
Subjects: ANTICORPOS MONOCLONAIS, NEOPLASIAS MAMÁRIAS, LIPOSSOMOS, ANTINEOPLÁSICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ELOY, Josimar O. et al. Anti-HER2 immunoliposomes for co-delivery of paclitaxel and rapamycin for breast cancer therapy. European Journal of Pharmaceutics and Biopharmaceutics, v. 115, p. 159-167, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.ejpb.2017.02.020. Acesso em: 14 jun. 2024.
APA
Eloy, J. O., Petrilli, R., Chesca, D. L., Saggioro, F. P., Lee, R. J., & Marchetti, J. M. (2017). Anti-HER2 immunoliposomes for co-delivery of paclitaxel and rapamycin for breast cancer therapy. European Journal of Pharmaceutics and Biopharmaceutics, 115, 159-167. doi:10.1016/j.ejpb.2017.02.020
NLM
Eloy JO, Petrilli R, Chesca DL, Saggioro FP, Lee RJ, Marchetti JM. Anti-HER2 immunoliposomes for co-delivery of paclitaxel and rapamycin for breast cancer therapy [Internet]. European Journal of Pharmaceutics and Biopharmaceutics. 2017 ; 115 159-167.[citado 2024 jun. 14 ] Available from: https://doi.org/10.1016/j.ejpb.2017.02.020
Vancouver
Eloy JO, Petrilli R, Chesca DL, Saggioro FP, Lee RJ, Marchetti JM. Anti-HER2 immunoliposomes for co-delivery of paclitaxel and rapamycin for breast cancer therapy [Internet]. European Journal of Pharmaceutics and Biopharmaceutics. 2017 ; 115 159-167.[citado 2024 jun. 14 ] Available from: https://doi.org/10.1016/j.ejpb.2017.02.020
Artigo de periodico
Rapamycin-loaded immunoliposomes functionalized with trastuzumab: a strategy to enhance cytotoxicity to HER2-positive breast cancer cells (2017)
Eloy, Josimar O.; Petrilli, Raquel; Brueggemeier, Robert W.; Marchetti, Juliana Maldonado; Lee, Robert J.
Source: Anti-Cancer Agents in Medicinal Chemistry. Unidade: FCFRP
Subjects: ANTINEOPLÁSICOS, NEOPLASIAS MAMÁRIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ELOY, Josimar O. et al. Rapamycin-loaded immunoliposomes functionalized with trastuzumab: a strategy to enhance cytotoxicity to HER2-positive breast cancer cells. Anti-Cancer Agents in Medicinal Chemistry, v. 17, n. 1, p. 48-56, 2017Tradução . . Disponível em: https://doi.org/10.2174/1871520616666160526103432. Acesso em: 14 jun. 2024.
APA
Eloy, J. O., Petrilli, R., Brueggemeier, R. W., Marchetti, J. M., & Lee, R. J. (2017). Rapamycin-loaded immunoliposomes functionalized with trastuzumab: a strategy to enhance cytotoxicity to HER2-positive breast cancer cells. Anti-Cancer Agents in Medicinal Chemistry, 17( 1), 48-56. doi:10.2174/1871520616666160526103432
NLM
Eloy JO, Petrilli R, Brueggemeier RW, Marchetti JM, Lee RJ. Rapamycin-loaded immunoliposomes functionalized with trastuzumab: a strategy to enhance cytotoxicity to HER2-positive breast cancer cells [Internet]. Anti-Cancer Agents in Medicinal Chemistry. 2017 ; 17( 1): 48-56.[citado 2024 jun. 14 ] Available from: https://doi.org/10.2174/1871520616666160526103432
Vancouver
Eloy JO, Petrilli R, Brueggemeier RW, Marchetti JM, Lee RJ. Rapamycin-loaded immunoliposomes functionalized with trastuzumab: a strategy to enhance cytotoxicity to HER2-positive breast cancer cells [Internet]. Anti-Cancer Agents in Medicinal Chemistry. 2017 ; 17( 1): 48-56.[citado 2024 jun. 14 ] Available from: https://doi.org/10.2174/1871520616666160526103432
Artigo de periodico
Co-loaded paclitaxel/rapamycin liposomes: development, characterization and in vitro and in vivo evaluation for breast cancer therapy (2016)
Eloy, Josimar O.; Petrilli, Raquel; Topan, José Fernando; Antonio, Heriton Marcelo Ribeiro; Barcellos, Juliana Palma Abriata; Chesca, Deise Lúcia; Serafini, Luciano Neder; Tiezzi, Daniel Guimarães; Lee, Robert J.; Marchetti, Juliana Maldonado
Source: Colloids and Surfaces B: Biointerfaces. Unidades: FMRP, FCFRP
Subjects: NEOPLASIAS MAMÁRIAS, LIPOSSOMOS, ANTINEOPLÁSICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ELOY, Josimar O. et al. Co-loaded paclitaxel/rapamycin liposomes: development, characterization and in vitro and in vivo evaluation for breast cancer therapy. Colloids and Surfaces B: Biointerfaces, v. 141, p. 74-82, 2016Tradução . . Disponível em: https://doi.org/10.1016/j.colsurfb.2016.01.032. Acesso em: 14 jun. 2024.
APA
Eloy, J. O., Petrilli, R., Topan, J. F., Antonio, H. M. R., Barcellos, J. P. A., Chesca, D. L., et al. (2016). Co-loaded paclitaxel/rapamycin liposomes: development, characterization and in vitro and in vivo evaluation for breast cancer therapy. Colloids and Surfaces B: Biointerfaces, 141, 74-82. doi:10.1016/j.colsurfb.2016.01.032
NLM
Eloy JO, Petrilli R, Topan JF, Antonio HMR, Barcellos JPA, Chesca DL, Serafini LN, Tiezzi DG, Lee RJ, Marchetti JM. Co-loaded paclitaxel/rapamycin liposomes: development, characterization and in vitro and in vivo evaluation for breast cancer therapy [Internet]. Colloids and Surfaces B: Biointerfaces. 2016 ; 141 74-82.[citado 2024 jun. 14 ] Available from: https://doi.org/10.1016/j.colsurfb.2016.01.032
Vancouver
Eloy JO, Petrilli R, Topan JF, Antonio HMR, Barcellos JPA, Chesca DL, Serafini LN, Tiezzi DG, Lee RJ, Marchetti JM. Co-loaded paclitaxel/rapamycin liposomes: development, characterization and in vitro and in vivo evaluation for breast cancer therapy [Internet]. Colloids and Surfaces B: Biointerfaces. 2016 ; 141 74-82.[citado 2024 jun. 14 ] Available from: https://doi.org/10.1016/j.colsurfb.2016.01.032
Artigo de periodico
Development of a method to evaluate the release profile of tamoxifen from pegylated hybrid micelles (2015)
Souza, Marina Claro de; Marotta-Oliveira, Samantha Sant'Anna; Rocha, Nathália Helena Souza; Eloy, Josimar O.; Marchetti, Juliana Maldonado
Source: Journal of Liquid Chromatography and Related Technologies. Unidade: FCFRP
Subjects: NEOPLASIAS MAMÁRIAS, ESTRÓGENOS, CROMATOGRAFIA LÍQUIDA DE ALTA EFICIÊNCIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, Marina Claro de et al. Development of a method to evaluate the release profile of tamoxifen from pegylated hybrid micelles. Journal of Liquid Chromatography and Related Technologies, v. 38, n. 12, p. 1223-1229, 2015Tradução . . Disponível em: https://doi.org/10.1080/10826076.2015.1032418. Acesso em: 14 jun. 2024.
APA
Souza, M. C. de, Marotta-Oliveira, S. S. 'A., Rocha, N. H. S., Eloy, J. O., & Marchetti, J. M. (2015). Development of a method to evaluate the release profile of tamoxifen from pegylated hybrid micelles. Journal of Liquid Chromatography and Related Technologies, 38( 12), 1223-1229. doi:10.1080/10826076.2015.1032418
NLM
Souza MC de, Marotta-Oliveira SS'A, Rocha NHS, Eloy JO, Marchetti JM. Development of a method to evaluate the release profile of tamoxifen from pegylated hybrid micelles [Internet]. Journal of Liquid Chromatography and Related Technologies. 2015 ; 38( 12): 1223-1229.[citado 2024 jun. 14 ] Available from: https://doi.org/10.1080/10826076.2015.1032418
Vancouver
Souza MC de, Marotta-Oliveira SS'A, Rocha NHS, Eloy JO, Marchetti JM. Development of a method to evaluate the release profile of tamoxifen from pegylated hybrid micelles [Internet]. Journal of Liquid Chromatography and Related Technologies. 2015 ; 38( 12): 1223-1229.[citado 2024 jun. 14 ] Available from: https://doi.org/10.1080/10826076.2015.1032418
Trabalho de evento-resumo
Avaliação do perfil in vitro de liberação do paclitaxel (2015)
Turatti, R. C.; Barcellos, J. P. A.; Marcato, P. D.; Marchetti, Juliana Maldonado
Source: Resumos da Faculdade de Ciências Farmacêuticas de Ribeirão Preto. Conference titles: Simpósio Internacional de Iniciação Científica da USP (SIICUSP). Unidade: FCFRP
Subjects: PESQUISA CIENTÍFICA, CIÊNCIA, TECNOLOGIA, ENSINO SUPERIOR, PROJETOS DE PESQUISA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TURATTI, R. C. et al. Avaliação do perfil in vitro de liberação do paclitaxel. 2015, Anais.. Ribeirão Preto: FCFRP-USP, 2015. Disponível em: https://uspdigital.usp.br/siicusp/siicPublicacao.jsp?codmnu=7210. Acesso em: 14 jun. 2024.
APA
Turatti, R. C., Barcellos, J. P. A., Marcato, P. D., & Marchetti, J. M. (2015). Avaliação do perfil in vitro de liberação do paclitaxel. In Resumos da Faculdade de Ciências Farmacêuticas de Ribeirão Preto. Ribeirão Preto: FCFRP-USP. Recuperado de https://uspdigital.usp.br/siicusp/siicPublicacao.jsp?codmnu=7210
NLM
Turatti RC, Barcellos JPA, Marcato PD, Marchetti JM. Avaliação do perfil in vitro de liberação do paclitaxel [Internet]. Resumos da Faculdade de Ciências Farmacêuticas de Ribeirão Preto. 2015 ;[citado 2024 jun. 14 ] Available from: https://uspdigital.usp.br/siicusp/siicPublicacao.jsp?codmnu=7210
Vancouver
Turatti RC, Barcellos JPA, Marcato PD, Marchetti JM. Avaliação do perfil in vitro de liberação do paclitaxel [Internet]. Resumos da Faculdade de Ciências Farmacêuticas de Ribeirão Preto. 2015 ;[citado 2024 jun. 14 ] Available from: https://uspdigital.usp.br/siicusp/siicPublicacao.jsp?codmnu=7210
Artigo de periodico
Preparation, characterization and evaluation of the in vivo trypanocidal activity of ursolic acid-loaded solid dispersion with poloxamer 407 and sodium caprate (2015)
Eloy, Josimar de Oliveira; Saraiva, Juliana; Albuquerque, Sérgio de; Marchetti, Juliana Maldonado
Source: Brazilian Journal of Pharmaceutical Sciences. Unidade: FCFRP
Subjects: FÁRMACOS (DESENVOLVIMENTO), DOENÇA DE CHAGAS, TRIPANOSSOMICIDAS (DESENVOLVIMENTO)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ELOY, Josimar de Oliveira et al. Preparation, characterization and evaluation of the in vivo trypanocidal activity of ursolic acid-loaded solid dispersion with poloxamer 407 and sodium caprate. Brazilian Journal of Pharmaceutical Sciences, v. 51, n. 1, p. 101-109, 2015Tradução . . Disponível em: https://doi.org/10.1590/S1984-82502015000100011. Acesso em: 14 jun. 2024.
APA
Eloy, J. de O., Saraiva, J., Albuquerque, S. de, & Marchetti, J. M. (2015). Preparation, characterization and evaluation of the in vivo trypanocidal activity of ursolic acid-loaded solid dispersion with poloxamer 407 and sodium caprate. Brazilian Journal of Pharmaceutical Sciences, 51( 1), 101-109. doi:10.1590/S1984-82502015000100011
NLM
Eloy J de O, Saraiva J, Albuquerque S de, Marchetti JM. Preparation, characterization and evaluation of the in vivo trypanocidal activity of ursolic acid-loaded solid dispersion with poloxamer 407 and sodium caprate [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2015 ; 51( 1): 101-109.[citado 2024 jun. 14 ] Available from: https://doi.org/10.1590/S1984-82502015000100011
Vancouver
Eloy J de O, Saraiva J, Albuquerque S de, Marchetti JM. Preparation, characterization and evaluation of the in vivo trypanocidal activity of ursolic acid-loaded solid dispersion with poloxamer 407 and sodium caprate [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2015 ; 51( 1): 101-109.[citado 2024 jun. 14 ] Available from: https://doi.org/10.1590/S1984-82502015000100011
Artigo de periodico
Liposomes as carriers of hydrophilic small molecule drugs: strategies to enhance encapsulation and delivery (2014)
Eloy, Josimar de Oliveira; Souza, Marina Claro de; Petrilli, Raquel; Barcellos, Juliana Palma Abriata; Lee, Robert J.; Marchetti, Juliana Maldonado
Source: Colloids and Surfaces B: Biointerfaces. Unidade: FCFRP
Subjects: LIPOSSOMOS, QUÍMICA FARMACÊUTICA, TECNOLOGIA FARMACÊUTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ELOY, Josimar de Oliveira et al. Liposomes as carriers of hydrophilic small molecule drugs: strategies to enhance encapsulation and delivery. Colloids and Surfaces B: Biointerfaces, v. 123, p. 345–363, 2014Tradução . . Disponível em: https://doi.org/10.1016/j.colsurfb.2014.09.029. Acesso em: 14 jun. 2024.
APA
Eloy, J. de O., Souza, M. C. de, Petrilli, R., Barcellos, J. P. A., Lee, R. J., & Marchetti, J. M. (2014). Liposomes as carriers of hydrophilic small molecule drugs: strategies to enhance encapsulation and delivery. Colloids and Surfaces B: Biointerfaces, 123, 345–363. doi:10.1016/j.colsurfb.2014.09.029
NLM
Eloy J de O, Souza MC de, Petrilli R, Barcellos JPA, Lee RJ, Marchetti JM. Liposomes as carriers of hydrophilic small molecule drugs: strategies to enhance encapsulation and delivery [Internet]. Colloids and Surfaces B: Biointerfaces. 2014 ; 123 345–363.[citado 2024 jun. 14 ] Available from: https://doi.org/10.1016/j.colsurfb.2014.09.029
Vancouver
Eloy J de O, Souza MC de, Petrilli R, Barcellos JPA, Lee RJ, Marchetti JM. Liposomes as carriers of hydrophilic small molecule drugs: strategies to enhance encapsulation and delivery [Internet]. Colloids and Surfaces B: Biointerfaces. 2014 ; 123 345–363.[citado 2024 jun. 14 ] Available from: https://doi.org/10.1016/j.colsurfb.2014.09.029
Artigo de periodico
Targeted lipid nanoparticles for antisense oligonucleotide delivery (2014)
Petrilli, Raquel; Eloy, Josimar de Oliveira; Marchetti, Juliana Maldonado; Lopez, Renata Fonseca Vianna; Lee, Robert J.
Source: Current Pharmaceutical Biotechnology. Unidade: FCFRP
Subjects: BIOTECNOLOGIA, FARMACOLOGIA, NANOPARTÍCULAS, OLIGONUCLEOTÍDEOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PETRILLI, Raquel et al. Targeted lipid nanoparticles for antisense oligonucleotide delivery. Current Pharmaceutical Biotechnology, v. 15, n. 9, p. 847-855, 2014Tradução . . Disponível em: https://doi.org/10.2174/1389201015666141020155834. Acesso em: 14 jun. 2024.
APA
Petrilli, R., Eloy, J. de O., Marchetti, J. M., Lopez, R. F. V., & Lee, R. J. (2014). Targeted lipid nanoparticles for antisense oligonucleotide delivery. Current Pharmaceutical Biotechnology, 15( 9), 847-855. doi:10.2174/1389201015666141020155834
NLM
Petrilli R, Eloy J de O, Marchetti JM, Lopez RFV, Lee RJ. Targeted lipid nanoparticles for antisense oligonucleotide delivery [Internet]. Current Pharmaceutical Biotechnology. 2014 ; 15( 9): 847-855.[citado 2024 jun. 14 ] Available from: https://doi.org/10.2174/1389201015666141020155834
Vancouver
Petrilli R, Eloy J de O, Marchetti JM, Lopez RFV, Lee RJ. Targeted lipid nanoparticles for antisense oligonucleotide delivery [Internet]. Current Pharmaceutical Biotechnology. 2014 ; 15( 9): 847-855.[citado 2024 jun. 14 ] Available from: https://doi.org/10.2174/1389201015666141020155834
Artigo de periodico
Propolis standardized extract (EPP-AF®), an innovative chemically and biologically reproducible pharmaceutical compound for treating wounds (2012)
Berretta, Andresa Aparecida; Nascimento, Andresa Piacezi; Bueno, Paula Carolina Pires; Vaz, Mirela Mara de Oliveira Lima Leite; Marchetti, Juliana Maldonado
Source: International Journal of Biological Sciences. Unidade: FCFRP
Subjects: PRÓPOLIS, CICATRIZAÇÃO, REPRODUTIBILIDADE DE RESULTADOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BERRETTA, Andresa Aparecida et al. Propolis standardized extract (EPP-AF®), an innovative chemically and biologically reproducible pharmaceutical compound for treating wounds. International Journal of Biological Sciences, v. 8, n. 4, p. 512-521, 2012Tradução . . Disponível em: https://doi.org/10.7150/ijbs.3641. Acesso em: 14 jun. 2024.
APA
Berretta, A. A., Nascimento, A. P., Bueno, P. C. P., Vaz, M. M. de O. L. L., & Marchetti, J. M. (2012). Propolis standardized extract (EPP-AF®), an innovative chemically and biologically reproducible pharmaceutical compound for treating wounds. International Journal of Biological Sciences, 8( 4), 512-521. doi:10.7150/ijbs.3641
NLM
Berretta AA, Nascimento AP, Bueno PCP, Vaz MM de OLL, Marchetti JM. Propolis standardized extract (EPP-AF®), an innovative chemically and biologically reproducible pharmaceutical compound for treating wounds [Internet]. International Journal of Biological Sciences. 2012 ; 8( 4): 512-521.[citado 2024 jun. 14 ] Available from: https://doi.org/10.7150/ijbs.3641
Vancouver
Berretta AA, Nascimento AP, Bueno PCP, Vaz MM de OLL, Marchetti JM. Propolis standardized extract (EPP-AF®), an innovative chemically and biologically reproducible pharmaceutical compound for treating wounds [Internet]. International Journal of Biological Sciences. 2012 ; 8( 4): 512-521.[citado 2024 jun. 14 ] Available from: https://doi.org/10.7150/ijbs.3641

USP Schools

ReP

Filtros

Document Types

USP Schools

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Publisher

Conference titles

Countries/Territories

Funding Agencies

Indexado em

Non normalized affiliation